Author

D. A. Bader

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. R. Cox· 2 shared C. Coarfa· 2 shared H. Wu· 2 shared J. B. Felix· 2 shared K. H. Kim· 2 shared N. Chernis· 2 shared P. M. Masschelin· 2 shared P. Saha· 2 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPhysiology

A. R. Cox

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Accumulation of auranofin in white adipose tissues lowers leptin levels and exerts anti-diabetic effects

A. R. Cox, P. M. Masschelin, P. Saha, J. B. Felix, R. Sharp, Z. Lian, Y. Xia, N. Chernis, D. A. Bader, K. H. Kim, X. Li, J. Yoshino, X. Li, Z. Sun, H. Wu, , S. M. Hartig

The paper identifies auranofin as a drug that lowers leptin levels in white adipose tissue and improves insulin sensitivity in obese mice, with anti-diabetic effects.

bioRxiv · Sep 11, 2021 · PreprintPhysiology

STAT1 dissociates adipose tissue inflammation from insulin sensitivity in obesity

A. R. Cox, N. Chernis, D. A. Bader, P. Saha, P. M. Masschelin, J. B. Felix, Z. Lian, V. Putluri, K. Rajapakshe, K. H. Kim, D. T. Villareal, R. Armamento-Villareal, H. Wu, C. Coarfa, N. Putluri, S. M. Hartig

The paper investigates how STAT1 activity in adipocytes affects insulin sensitivity in obesity, finding that STAT1 deletion improves mitochondrial function but does not resolve insulin resistance.

bioRxiv · Apr 10, 2020Immunology